The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
Open accessAbstract
HIV-1 entry into CD4+cells requires the sequential interactions of the viral envelope glycoproteins with CD4 and a coreceptor such as the chemokine receptors CCR5 and CXCR4. A plausible approach to blocking this process is to use small molecule antagonists of coreceptor function. One such inhibitor has been described for CCR5: the TAK-779 molecule. To facilitate the further development of entry inhibitors as antiviral drugs, we have explored how TAK-779 acts to prevent HIV-1 infection, and we have mapped its site of interaction with CCR5. We find that TAK-779 inhibits HIV-1 replication at the membrane fusion stage by blocking the interaction of the viral surface glycoprotein gp120 with CCR5. We could identify no amino acid substitutions within the extracellular domain of CCR5 that affected the antiviral action of TAK-779. However, alanine scanning mutagenesis of the transmembrane domains revealed that the binding site for TAK-779 on CCR5 is located near the extracellular surface of the receptor, within a cavity formed between transmembrane helices 1, 2, 3, and 7.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Self-citationLiu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00002 · Cited by 843
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Self-citationA small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry
Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N. P., Gerard, C., Sodroski, J., & Choe, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80577-2 · Cited by 693
Chemokine receptors: Gateways to inflammation and infection
Premack, B. A., & Schall, T. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1174 · Cited by 630
Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stanton, J. L., Macken, C. A., Perelson, A. S., & Wolinsky, S. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402102 · Cited by 611
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Moore, J. P., Trkola, A., & Dragic, T. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80110-0 · Cited by 495
Self-citationLoetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., & Moser, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42339-8 · Cited by 445
White, J. R., Lee, J. M., Young, P. R., Hertzberg, R. P., Jurewicz, A. J., Chaikin, M. A., Widdowson, K., Foley, J. J., Martin, L. D., Griswold, D. E., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10095 · Cited by 432
A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection
Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1389 · Cited by 398
Transmission of antiretroviral-drug-resistant HIV-1 variants
Yerly, S., Kaiser, L., Race, E., Bru, J.-P., Clavel, F., & Perrin, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12262-6 · Cited by 389
Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1373 · Cited by 357
Self-citationLatent reservoirs of HIV: Obstacles to the eradication of virus
Chun, T.-W., & Fauci, A. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10958 · Cited by 342
Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., & O'Brien, W. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1395 · Cited by 336
Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity
Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81364-1 · Cited by 290
The AIDS Epidemic — Considerations for the 21st Century
Fauci, A. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411406 · Cited by 257
Zhou, Y., Kurihara, T., Ryseck, R.-P., Yang, Y., Ryan, C., Loy, J., Warr, G., & Bravo, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4018 · Cited by 245
Siciliano, S. J., Rollins, T. E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., & Springer, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1214 · Cited by 233
Kozak, S. L., Platt, E. J., Madani, N., Ferro, F. E., Peden, K., & Kabat, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.873-882.1997 · Cited by 226
Olson, W. C., Rabut, G. E. E., Nagashima, K. A., Tran, D. N. H., Anselma, D. J., Monard, S. P., Segal, J. P., Thompson, D. A. D., Kajumo, F., Guo, Y., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4145-4155.1999 · Cited by 224
Self-citationTwo distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
Doranz, B. J., Lu, Z. H., Rucker, J., Zhang, T. Y., Sharron, M., Cen, Y. H., Wang, Z. X., Guo, H. H., Du, J. G., Accavitti, M. A., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6305-6314.1997 · Cited by 214
Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., Zhao, L., Olson, W. C., Wu, L., Mackay, C. R., Allaway, G. P., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.279-285.1998 · Cited by 212
Self-citationMonteclaro, F. S., & Charo, I. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19084 · Cited by 206
Trkola, A., Matthews, J., Gordon, C., Ketas, T., & Moore, J. P. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8966-8974.1999 · Cited by 180
Self-citationHuffnagle, G. B., McNeil, L. K., McDonald, R. A., Murphy, J. W., Toews, G. B., Maeda, N., & Kuziel, W. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4642 · Cited by 166
Hesselgesser, J., Ng, H. P., Liang, M., Zheng, W., May, K. E., Bauman, J. G., Monahan, S. D., Islam, I., Guo, W., Ghannam, A. F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15687 · Cited by 152
Labrosse, B., Brelot, A., Heveker, N., Sol‐Foulon, N., Schols, D., Clercq, E. D., & Alizon, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6381-6388.1998 · Cited by 142
HIV-1 entry inhibitors: Evading the issue
Michael, N. L., & Moore, J. P. (1999) · Nature Medicine · doi:10.1038/10462 · Cited by 135
Self-citationChen, Z., Kwon, D. S., Jin, Z., Monard, S. P., Telfer, P., Jones, M. S., Lu, C. Y., Aguilar, R., Ho, D. D., & Marx, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2057 · Cited by 125
Picard, L., Simmons, G., Power, C., Meyer, A., Weiss, R. A., & Clapham, P. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5003-5011.1997 · Cited by 123
Rabut, G. E. E., Konner, J. A., Kajumo, F., Moore, J. P., & Dragic, T. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3464-3468.1998 · Cited by 120
Self-citationThe steric trigger in rhodopsin activation
Shieh, T., Han, M., Sakmar, T. P., & Smith, S. O. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1035 · Cited by 94
Self-citationInhibition of G-protein-coupled Receptor Function by Disruption of Transmembrane Domain Interactions
Tarasova, N. I., Rice, W. G., & Michejda, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34911 · Cited by 88
Hill, C. M., Kwon, D. S., Jones, M. S., Davis, C. B., Marmon, S., Daugherty, B. L., DeMartino, J. A., Springer, M. S., Unutmaz, D., & Littman, D. R. (1998) · Virology · doi:10.1006/viro.1998.9283 · Cited by 59
HIV infection: where have all the T cells gone?
Rowland-Jones, S. L. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90017-x · Cited by 55
Cited by
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Chemokine:Receptor Structure, Interactions, and Antagonism
Allen, S. J., Crown, S. E., & Handel, T. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090529 · Cited by 839
Unraveling hot spots in binding interfaces: progress and challenges
DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767
Metadata
- Authors
- Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., & Moore, J. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-04-25
- Volume
- 97
- Issue
- 10
- Pages
- 5639-5644
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2044004371
- Cited by
- 426
- References
- 46
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.